Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHPL-49 in Acute Ischemic Stroke (SAIL)
NCT07241520Phase 3Recruiting
- Start
- Dec 2025
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of SHPL-49 in ischemic stroke. Started Dec 2025; status: recruiting.
02
Drugs
SHPL-49
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07241520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07241520.